These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 33483853)

  • 1. Comparison of Prospective and Retrospective Methods of a Tigecycline Post-Marketing Surveillance Study in the Safety Outcomes of Patients with Complicated Skin Structure Infection, Complicated Intraabdominal Infection and Community-Acquired Pneumonia.
    Chi W; Lee HJ; Chong YP
    Infect Dis Ther; 2021 Mar; 10(1):411-420. PubMed ID: 33483853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Open Label, Multi-Center, Non-Interventional Post-Marketing Surveillance to Monitor the Safety and Efficacy of ALTARGO® (Retapamulin) Administered in Korean Patients According to the Prescribing Information.
    Hong W; Lee YS; Park CW; Yoon MS; Ro YS
    Ann Dermatol; 2018 Aug; 30(4):441-450. PubMed ID: 30065584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug use investigation on the safety and efficacy of tigecycline in Japan (all-case post-marketing surveillance).
    Ohashi T; Sugiyama N; Watanabe T; Uryu T; Yoshinaga Y
    J Infect Chemother; 2022 Jul; 28(7):866-874. PubMed ID: 35367148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and effectiveness of tadalafil in patients with pulmonary arterial hypertension: Japanese post-marketing surveillance data.
    Yamazaki H; Kobayashi N; Taketsuna M; Tajima K; Murakami M
    Curr Med Res Opin; 2017 May; 33(5):963-971. PubMed ID: 28277870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-marketing surveillance on the long-term use of dabigatran in Japanese patients with nonvalvular atrial fibrillation: Preliminary report of the J-dabigatran surveillance.
    Inoue H; Uchiyama S; Atarashi H; Okumura K; Koretsune Y; Yasaka M; Yamashita T; Ohnishi M; Yagi N; Fukaya T;
    J Arrhythm; 2016 Apr; 32(2):145-50. PubMed ID: 27092197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-marketing surveillance to assess the safety and tolerability of a combined diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine (DTaP-IPV) in Korean children.
    Lee SM; Kim SJ; Chen J; Song R; Kim JH; Devadiga R; Kim YK
    Hum Vaccin Immunother; 2019; 15(5):1145-1153. PubMed ID: 30668217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of Rapamune® (Sirolimus) in kidney transplant recipients: results of a prospective post-marketing surveillance study in Korea.
    Jeon HJ; Lee HE; Yang J
    BMC Nephrol; 2018 Aug; 19(1):201. PubMed ID: 30103684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of bazedoxifene in Korean women with post-menopausal osteoporosis: a post-marketing surveillance study (PMSS).
    Kim JW; Lee JY; Park HE; Kim SH; Chung YS
    Expert Opin Drug Saf; 2019 Oct; 18(10):1001-1008. PubMed ID: 31394044
    [No Abstract]   [Full Text] [Related]  

  • 9. Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis.
    Cohen S; Curtis JR; DeMasi R; Chen Y; Fan H; Soonasra A; Fleischmann R
    Rheumatol Ther; 2018 Jun; 5(1):283-291. PubMed ID: 29470834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-year multi-centre, observational, post-marketing surveillance of the safety of the HPV-16/18 AS04-adjuvanted vaccine in women aged 10-25 years in Korea.
    Kim CJ; Song R; Chen J; Tavares Da Silva F; Gopala KB; Kim JH; Bi D; Park JS
    Pharmacoepidemiol Drug Saf; 2017 Jul; 26(7):837-842. PubMed ID: 28266092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tigecycline use in cancer patients with serious infections: a report on 110 cases from a single institution.
    Chemaly RF; Hanmod SS; Jiang Y; Rathod DB; Mulanovich V; Adachi JA; Rolston KV; Raad II; Hachem RY
    Medicine (Baltimore); 2009 Jul; 88(4):211-220. PubMed ID: 19593226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and effectiveness of 24-week treatment with iguratimod, a new oral disease-modifying antirheumatic drug, for patients with rheumatoid arthritis: interim analysis of a post-marketing surveillance study of 2679 patients in Japan.
    Mimori T; Harigai M; Atsumi T; Fujii T; Kuwana M; Matsuno H; Momohara S; Takei S; Tamura N; Takasaki Y; Ikeuchi S; Kushimoto S; Koike T
    Mod Rheumatol; 2017 Sep; 27(5):755-765. PubMed ID: 27919207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of tigecycline used as monotherapy or in combination regimens for complicated infections with documented involvement of multiresistant bacteria.
    Heizmann WR; Löschmann PA; Eckmann C; von Eiff C; Bodmann KF; Petrik C
    Infection; 2015 Feb; 43(1):37-43. PubMed ID: 25367409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world evidence for the safety of ipragliflozin in elderly Japanese patients with type 2 diabetes mellitus (STELLA-ELDER): final results of a post-marketing surveillance study.
    Yokote K; Terauchi Y; Nakamura I; Sugamori H
    Expert Opin Pharmacother; 2016 Oct; 17(15):1995-2003. PubMed ID: 27477242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and effectiveness of oral medium to high dose blonanserin in patients with schizophrenia: subgroup analysis from a prospective, multicenter, post-marketing surveillance study in mainland China.
    Yang Y; Ge H; Wang X; Liu X; Li K; Wang G; Yang X; Deng H; Sun M; Zhang R; Chen J; Cai D; Sang H; Liu X; Zhan G; Zhao G; Li H; Xun Z
    Ann Gen Psychiatry; 2023 Oct; 22(1):37. PubMed ID: 37803378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: pooled results from 8 phase III clinical trials.
    Gardiner D; Dukart G; Cooper A; Babinchak T
    Clin Infect Dis; 2010 Jan; 50(2):229-38. PubMed ID: 20025527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan.
    Adachi M; Kozawa M; Yoshisue H; Lee Milligan K; Nagasaki M; Sasajima T; Miyamoto T; Ohta K
    Respir Med; 2018 Aug; 141():56-63. PubMed ID: 30053973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia.
    Choi GS; Kim JH; Oh SY; Park JM; Hong JS; Lee YS; Lee WS
    Ann Dermatol; 2016 Aug; 28(4):444-50. PubMed ID: 27489426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: insight from a pharmacovigilance study.
    Gatti M; Raschi E; De Ponti F
    BMC Pharmacol Toxicol; 2019 Nov; 20(1):65. PubMed ID: 31718688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.